Metabolic research
Most requested
Retatrutide
Triple-agonist metabolic research peptide targeting GLP-1, GIP and glucagon receptors.
- Purity:
- ≥99% HPLC
- Sizes available:
- 10 mg
CagriSema
Cagrilintide and semaglutide in one vial, 5 mg of each.
Customers
CagriSema
Cagrilintide and semaglutide in one vial, 5 mg of each.
Format
Pen format is not yet available
We currently supply lyophilised vials only. Pre-filled pen devices are in development — join the waitlist and we will notify you when they are available.
5 mg + 5 mg
- Purity
- ≥99% HPLC
- Physical form
- Lyophilised powder
- Testing
- HPLC + mass spectrometry, per batch
This compound cannot be bought online: ask us about it. The ones that can are on the pricing page.
Consult about CagriSemaNo payment. No account. No obligation. One business day response.
Request the Certificate of Analysis (CoA)
What the research says
CagriSema is the name of the combination of cagrilintide, a long-acting amylin analogue, and semaglutide, a GLP-1 receptor agonist. Novo Nordisk tested it in the REDEFINE phase 3 programme: REDEFINE 1 enrolled adults with overweight or obesity (Garvey et al., N Engl J Med 2025) and REDEFINE 2 adults with obesity and type 2 diabetes (Davies et al., N Engl J Med 2025), both over 68 weeks. The idea behind the pairing is two different satiety pathways at once, amylin and GLP-1. The combination has not received FDA approval. PeptoClinic supplies both peptides in one lyophilized vial, 5 mg of each.
- Purity
- ≥99% HPLC
- Research area
- Metabolic research
Also known as: cagrilintide-semaglutide, cagrilintide and semaglutide
Metabolic research
≥99% HPLC
Sizes available: 5 mg + 5 mg
Physician-reviewed
- Independent laboratory Freedom Diagnostics
- Lowest published purity 99.01%
- Published certificates 43
- Content weighed, not claimed 36
- Verifiable with the lab's key 43
Documented research areas
- Amylin + GLP-1
- REDEFINE 1 and 2
- Two-peptide vial
CagriSema specifications
| Property | Specification |
|---|---|
| Classification | Cagrilintide + semaglutide, 5 mg + 5 mg in one vial |
| Also known as | cagrilintide-semaglutide, cagrilintide and semaglutide |
| Purity | ≥99% HPLC |
| Vial sizes available | 5 mg + 5 mg |
| Intended use | Supplied after physician review — not an approved medicine |
| Physical form | Lyophilised powder |
| Storage | -20 °C, protected from light |
| Reconstitution | Bacteriostatic water · 10 ml bottle, included at no charge (one per vial) |
| Testing | HPLC + mass spectrometry, per batch |
| Dispatch | Sealed box, tracked, from Argentina or the United States — no cold chain needed |
Certificate of analysis
The CoA for the specific batch you would receive is reviewed during your consultation and ships with the material.
Request this batch CoAFrequently asked questions
How do I know a lot is what it claims to be?
From that lot's certificate of analysis, not from what the supplier asserts. The certificate names the laboratory that took the measurement, the date, the task number, the method and the purity found. PeptoClinic publishes the full reports uncropped, exactly as the laboratory printed them.
What is a certificate of analysis and how do you read one?
It is the report an analytical laboratory issues on a specific sample. Four things are worth checking: which compound it claims to have measured, by what method (HPLC for purity, mass spectrometry for identity), what figure it found, and whether the task number can be verified against the laboratory. A certificate with no verifiable task number is a picture.
People also ask about
Metabolic research
Tirzepatide
Dual GIP and GLP-1 receptor agonist, the molecule in Mounjaro and Zepbound.
- Purity:
- ≥99% HPLC
- Sizes available:
- 15 mg – 30 mg
Supplied after physician review — not an approved medicine